by Life Science Newswire | Sep 30, 2019 | Clinical Research & Trials, Drug Discovery & Development, Energy & Environment, General Laboratory, Materials Science, Pharma
Today, we’re proud to announce the launch of the Research on Research Institute (RoRI) – an international consortium of research funders, academic institutions, and technologists working to champion the latest approaches to research on research. Co-founded by the...
by Life Science Newswire | Sep 19, 2019 | Biotechnology, Computing & Technology, Drug Discovery & Development, Pharma
The space occupied by a drug molecule in three dimensions, and how it fits into the target, is an important consideration when designing a new compound that might become a drug. Medicinal chemists commonly use 3D rendering software to visualise the shape of molecules...
by Life Science Newswire | Sep 12, 2019 | Corporate, Finance & Investor, Drug Discovery & Development, Pharma
Sygnature Discovery, the leading independent drug discovery and pre-clinical services company, has today announced its US office has moved. The new office, at 245 First Street in Cambridge, MA, is near Kendall Square, the heart of the Cambridge–Boston biotech hub....
by Life Science Newswire | Sep 11, 2019 | Biomanufacturing, Biotechnology, Clinical Research & Trials, Computing & Technology, Drug Discovery & Development, General Science, Healthcare, Pharma
Digital Science has today launched a report focusing on falsifiability and reproducibility in scientific research. The report addresses three areas including appropriate documentation and sharing of research data, clear analysis and processes, and the sharing of code....
by Life Science Newswire | Sep 3, 2019 | Corporate, Finance & Investor, Healthcare, Pharmacy
BioCity, the pioneering life science incubator and business collective has today announced investment in Maxwellia. The world’s first prescription (Rx) to Over the Counter (OTC) switch incubator, Maxwellia’s novel approach converts prescription drugs into versions...
Recent Comments